| Financial Year |
March 31 2023 |
| Monetary Funds |
7,936,762,141.46 |
| Held-for-trading Financial Assets |
2,651,342,018.15 |
| Notes Receivable |
1,375,977,079.85 |
| Accounts Receivable |
1,885,514,514.76 |
| Advances to Suppliers |
1,775,596,425.33 |
| Other Receivables |
319,781,599.91 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
5,402,985.53 |
| Dividend Receivable |
-- |
| Inventories |
2,697,423,586.28 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
369,981,885.95 |
| Total Current Assets |
22,718,422,354.99 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
1,122,748,615.46 |
| Investment Properties |
-- |
| Fixed Assetes |
38,765,198,528.24 |
| Under-construction Projects |
2,471,345,788.51 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
16,151,194,660.90 |
| R&D expenses |
-- |
| Goodwill |
186,080,706.18 |
| Long-Term Deferred and Prepaid Expenses |
12,852,060.04 |
| Deferred Income Tax Assets |
1,106,021,299.00 |
| Other Non-Current Assets |
1,313,933,572.29 |
| Sub-Total of Non-Current Assets |
64,306,407,128.06 |
| Total Assets |
87,024,829,483.05 |
| Short-Term Loans |
1,493,402,653.55 |
| Trading Financial liabilities |
-- |
| Notes Payable |
1,845,981,135.61 |
| Accounts Payable |
11,369,636,691.47 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
2,396,176,241.93 |
| Taxes Payable |
1,170,073,153.88 |
| Interest Payable |
21,532,056.22 |
| Dividend Payable |
-- |
| Other payables |
2,912,319,122.90 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
3,088,951,164.21 |
| Other Current Liabilities |
62,898,784.70 |
| Sub-Total of Current Liabilities |
27,154,695,296.59 |
| Long-term Loans |
5,832,769,360.00 |
| Bonds Payable |
2,816,989,242.92 |
| Long-Term Accounts Payable |
2,642,033,295.03 |
| Special Payable |
-- |
| Estimatied Liabilities |
3,758,131,072.46 |
| Deferred Income Tax Liabilities |
917,907,070.35 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
19,343,719,848.24 |
| Total Liabilities |
46,498,415,144.83 |
| Paid-In Capital(Or Share Stock) |
2,481,037,228.00 |
| Capital Surplus |
8,376,519,786.49 |
| Surplus Reserve |
1,680,605,888.21 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
21,706,592,987.20 |
| Minority Stockholder's Interest |
4,599,267,854.03 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
35,927,146,484.19 |
| Owner's Equity（Stockholder's Equity） |
40,526,414,338.22 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
87,024,829,483.05 |
